MOBI introduces GLP-1 Home Wellness Kit to track health at home
MOBI is addressing a practical at-home need.
GLP-1
GLP-1 users are spending nearly 4x more on fitness than other consumers, new report reveals
The Consumer Collective's national study of 500 U.S. adults shows GLP-1 users spend $449 a month on fitness, against $120 for non-users.
Study finds Zepbound cuts healthcare costs for older adults with obesity
Study shows sustained Zepbound use in older adults with obesity lowers costs, reinforcing the potential value of the Medicare GLP-1 Bridge program.
U.S. News debuts 2026-2027 best GLP-1 telehealth platform ratings
Inaugural ratings evaluate leading online GLP-1 platforms to help consumers make informed decisions in the fast-growing weight management market.
CVS Health broadens consumer access to GLP-1 weight management
Offers all FDA approved GLP-1s, whether through insurance or cash-pay options.
Publix pharmacies join Medicare GLP-1 Bridge program for eligible beneficiaries
The GLP-1 medications currently available through the program include Foundayo, Wegovy in both injectable and tablet forms, and Zepbound KwikPen.
Shoppers Drug Mart and Obesity Canada team to help expand access to obesity care for Canadians
Alliance supports education, stigma reduction, and access to multidisciplinary care for eligible Canadians seeking support for obesity and long-term weight management.
Kroger Health: Five ways to get the most from a GLP-1 medication
Kroger Health dietitians share practical guidance for patients navigating weight-management treatment as part of Kroger's new GLP-1 Complete Support Program.
Hartig Drug rolls out GLP-1 Coordination and Education Program
Aims to help patients find affordable GLP-1 medication options.
Hy-Vee rolls out GLP-1 wellness program, offers free enrollment to first 1,000 sign-ups
The program follows the recent launch of Medicare’s new GLP-1 Bridge program.
Wegovy now accessible to eligible Medicare beneficiaries living with obesity through Medicare GLP-1 Bridge
eligible Medicare patients living with obesity can access Wegovy® (semaglutide) injection and pill for a $50 monthly copay
Walmart and Sam’s Club expand support for Medicare customers
New initiative expands access to trusted information, pharmacy support, and healthcare navigation resources for Medicare beneficiaries as Medicare GLP-1 Bridge program launches.
CVS Pharmacy expands GLP‑1 support to cut costs, boost access and help patients stay on therapy
Eligible Medicare patients can access support through a new $50 monthly copay, including one-on-one pharmacist guidance and over-the-counter products to help manage common side effects.
Wegovy pill prescriptions hit a milestone
Surpasses 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated.
Stevanato Group unveils Deora, a pen injector for subcutaneous delivery in diabetes and weight management
The fixed-dose, multi-use pen injector platform features a pull-push mechanism designed to reduce use error while supporting delivery volumes up to 0.75 mL.
Buying outside the pharmacy: 45% of peptide users who source from social media have visited the ER
A new Sunlight survey of 1,000 U.S. peptide users finds that gray-market buyers visit the ER at 3x the rate of all peptide users. Three in four of these buyers have told their doctor about their peptide use, but the doctor never sees what was bought on social media.